Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1001/jamanetworkopen.2022.45077

Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

Michele Bartoletti & Fabio Puglisi et al. · 2022-12-01

5Citations

This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer.

Links

DOI PubMed

Journal

JAMA Network Open

TL;DR

This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer to determine the effectiveness of these treatments.

AI-generated by Semantic Scholar

Authors

Michele Bartoletti, Sandro Pignata, Domenica Lorusso, Francesco Perrone, Diego Zara, Fabio Puglisi